OTC - ACTIVE INGREDIENT SECTION
glycerin
glycerin
water, butylene glycol, niacinamide, cetyl ethylhexanoate, grapefruit fruit ext, ceratonia siliqua gum, carrageenan, glyceryl stearate, cellulose gum, sodium polyacrylate, hydrogenated polydecene, adenosine, hydrolyzed gollagen, adansonia digitata leaf ext, trideceth-6, rosa centifolia flower ext, camellia sinensis leaf ext, aloe barbadensis leaf ext, sodium hyaluronate, copper tripeptide-1, disodium edta, phenoxyethanol, fragrance
whitening, anti-wrinkle
keep out of reach of the children
clarify the face and tone the skin texture using the toner, peel off the fabric sheet from gel patch
gently apply the mask to fit the contours of your face and take off the film of gel patch
remove the gel mask hafter 30 minutes later, absorb it with tight tapping and finish
if you notice any skin trouble or other unexpected reaction such as rash, irritation discontinue use immediately and ask a doctor
do not expose this product directly to the sun and store in a cool dry place
for external use only
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58895-1001-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-db1a-cd31-e053-dbdaa90ab51a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58895-1001-1 | MODLINA PEPTIDE SOOTHING ESSENTIAL HYDROGEL MASK PACK | 25 g in 1 PACKAGE | LIQUID | 25 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58895-1001 | MODLINA PEPTIDE SOOTHING ESSENTIAL HYDROGEL MASK PACK (GLYCERIN) LIQUID [MODLINA COSMETICS CO., LTD] | 1 | Legacy NDC, 1 package rows | 20130812_e6c7be82-d70a-461d-b04b-e59288089a44.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| CETYL ETHYLHEXANOATE | INACTIVE INGREDIENT | 134647WMX4 | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58895-1001 | 58895-1001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | ACTIB |
| WATER | 059QF0KO0R | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| NIACINAMIDE | 25X51I8RD4 | IACT |
| CETYL ETHYLHEXANOATE | 134647WMX4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAVENOUS | 2.5 %w/v | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 896c4911-af27-4a5e-8015-17c5c83cfdc1 | e6c7be82-d70a-461d-b04b-e59288089a44 | 2013-08-12 | Warnings | 896c4911-af27-4a5e-8015-17c5c83cfdc1 e6c7be82-d70a-461d-b04b-e59288089a44 |
Adverse event summaries are temporarily unavailable. Other product information remains available.